Cargando…
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
Mantle cell lymphoma (MCL) is an aggressive B cell lymphoma with poor long-term overall survival. Currently, MCL research and development of potential cures is hampered by the lack of good in vivo models. MCL is characterized by recurrent translocations of CCND1 or CCND2, resulting in overexpression...
Autores principales: | Pieters, Tim, T’Sas, Sara, Vanhee, Stijn, Almeida, André, Driege, Yasmine, Roels, Juliette, Van Loocke, Wouter, Daneels, Willem, Baens, Mathijs, Marchand, Arnaud, Van Trimpont, Maaike, Matthijssens, Filip, Morscio, Julie, Lemeire, Kelly, Lintermans, Béatrice, Reunes, Lindy, Chaltin, Patrick, Offner, Fritz, Van Dorpe, Jo, Hochepied, Tino, Berx, Geert, Beyaert, Rudi, Staal, Jens, Van Vlierberghe, Pieter, Goossens, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377631/ https://www.ncbi.nlm.nih.gov/pubmed/34406363 http://dx.doi.org/10.1084/jem.20202280 |
Ejemplares similares
-
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
por: Pieters, Tim, et al.
Publicado: (2019) -
MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner
por: Demeyer, Annelies, et al.
Publicado: (2019) -
Myb drives B-cell neoplasms and myeloid malignancies in vivo
por: Pieters, Tim, et al.
Publicado: (2022) -
P326: A DUAL ROLE FOR PSIP1 IN T-ALL
por: Demoen, Lisa, et al.
Publicado: (2023) -
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
por: Provez, Lien, et al.
Publicado: (2023)